Remy Buser's journey from studying at ETH to founding Bloom Biorenewables and how he emphasises the need to defossilise materials and find sustainable alternatives.

Remy Buseris on a mission to replace fossil carbon with renewable carbon in the chemical industry! The CEO and co-founder of Bloom Biorenewables explains how the use of petrochemicals has shaped our world and the need to defossilise materials. He discusses the complexity of the transition and the role of political commitment and scientific understanding in driving this change. Remy emphasises the need for a global perspective and collaboration to tackle climate challenges. The conversation also touches on Remy's personal experiences, including his time at ETH and his passion for understanding the materials that shape our world.

This is his story.

Podcasts mentioned in the episode:

· Podcasts of The Economist

· Podcast with Jean-Marc Jancovici

Chapters:

(00:00) Introduction and the Need to Defossilize Materials

(03:05) Remy Busse's Background and the Story of Truffles

(05:23) From Swiss Blot to Bloom BioRenewables

(09:00) Moving Away from Fossil-Based Carbon

(11:45) The Role of Petrochemicals in the Chemical Industry

(15:34) Replacing the Petrochemical Sector with Biomass

(20:19) Working with Politicians on Environmental Bills

(21:42) The Importance of Politics in Addressing Climate Change

(23:35) Childhood Aspirations and Curiosity about Materials

(28:52) Favorite Places in Zurich

Wim Thiery, a climate scientist and associate professor at the University of Brussels, revealed during his recent visit at ETH Zurich, that children born in 2020 will face significantly more extreme weather events than previous generations.

Wim Thiery, climate scientist and Associate Professor at the University of Brussels, talks about the urgent need for robust mitigation and adaptation strategies to address the increasing frequency and intensity of these climate phenomena.

He also highlights the critical role of climate scientists in informing litigation against governments and corporations failing to take sufficient climate action.

Thiery shares with us his background and experiences that have shaped his career and gives an inspiring insight into the life of a scientist who wants to make a difference.

This is his story.

Chapters

(00:00) Introduction to Climate Injustice

(00:16) Meet Wim Thierry: Climate Scientist

(01:10) Seminar Insights: Unprecedented Lives

(01:30) Intergenerational Climate Inequities

(02:30) Heatwaves and Future Climate Scenarios

(03:30) Global Climate Extremes and Regional Disparities

(09:33) The Urgency of Climate Action and Adaptation

(10:26) Three Pillars of Climate Action

(12:54) My Climate Future: Personalized Climate Impact

(13:42) The Role of AI in Climate Research

(15:40) Preparing Future Generations for Climate Challenges

(17:08) Climate Litigation and the Role of Scientists

(19:12) Wim Thierry's Academic Journey

(22:18) Closing Thoughts and Personal Reflections

(25:32) Final Words and Podcast Outro

Oriana Kraft, entrepreneur and founder of the FemTechnology Summit explains the need for gender-specific care in medicine and the potential of FemTech to revolutionise healthcare.

In this episode, Oriana Kraft, founder of Fem Technology, delves into the gender data health gap and the burgeoning field of FemTech. Fem Technology specialises in solutions that improve women's healthcare in the areas of reproductive health, autoimmune diseases and cardiovascular health. The conversation highlights the need for gender-specific care in medicine and FemTech's potential to revolutionise healthcare. Oriana shares insights from organising the first FemTechnology Summit at ETH and the collaboration with Roche. The episode concludes with a discussion about the synergy between science and art and Oriana's favorite spots in Zurich.

This is her story.

Chapters

(00:00) Introduction and Queen Victoria's Endometriosis

(04:29) The FEM Tech Guide and Proactive Women's Health Solutions

(13:51) Collaboration with Roche and the Role of Big Pharma in Femtech

(22:30) From Medicine to Entrepreneurship and the Intersection of Science and Art